Publicacións en colaboración con investigadores/as de Complexo Hospitalario Universitario de Santiago (135)

2024

  1. Correction to: Camrelizumab-based induction chemoimmunotherapy in locally advanced stage hypopharyngeal carcinoma: phase II clinical trial (Nature Communications, (2024), 15, 1, (5251), 10.1038/s41467-024-49121-3)

    Nature Communications

  2. Correction to: dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe (Nature Communications, (2024), 15, 1, (3736), 10.1038/s41467-024-47751-1)

    Nature Communications

  3. Corrigendum to "Red Blood Cells Protein Profile Is Modified in Breast Cancer Patients"

    Molecular & cellular proteomics : MCP

  4. Genetic linkage analysis of head and neck cancer in a Spanish family

    Oral Diseases, Vol. 30, Núm. 3, pp. 1032-1039

  5. Human recombinant relaxin-2 (serelaxin) regulates the proteome, lipidome, lipid metabolism and inflammatory profile of rat visceral adipose tissue

    Biochemical Pharmacology, Vol. 223

  6. Identification of a Proteomic Signature for Predicting Immunotherapy Response in Patients With Metastatic Non-Small Cell Lung Cancer

    Molecular and Cellular Proteomics, Vol. 23, Núm. 10

  7. Signature Proteins in Small Extracellular Vesicles of Granulocytes and CD4+ T-Cell Subpopulations Identified by Comparative Proteomic Analysis

    International Journal of Molecular Sciences, Vol. 25, Núm. 19

  8. Using SWATH-MS to identify new molecular biomarkers in gingival crevicular fluid for detecting periodontitis and its response to treatment

    Journal of Clinical Periodontology, Vol. 51, Núm. 10, pp. 1342-1358

  9. dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe

    Nature Communications, Vol. 15, Núm. 1